BioAI
A company founded by pharmaceutical CEOs and artificial intelligence experts.
Company Overview
2019
2020
2021
2022
Jan.
Company Established
Aug.
Dec.
Dec.
4 Drug AI Patent applications
2 Paper Published
Selected Global startup accelerating program start-up Chile 'Drug-Drug interaction prediction platform'
The Ministry of SMEs and Startups
for the start-up growth R&D project
selected the "Deep Learning New Drug Candidate Discovery Platform"
Business Areas
BioAI uses a supercomputer to manage and analyze biopharmaceutical big data, and produce and supply customized artificial intelligence solutions through this.
A platform for discovering new drug candidates with artificial intelligence. It not only enables physical savings of the enormous time and cost of research and development of pharmaceuticals, but also enables new drug research using the characteristics of human and other artificial intelligence.
Research Papers
Segyu Lee, Junil Bang, Sungeun Hong, Woojung Jang.(2021). Abcnet : self-attention based atom, bond message passing network for predicting drug-target interaction. bioRxiv, doi: https://doi.org/10.1101/2021.12.27.474154
Junil Bang, Segyu Lee, Sungen Hong, Seon Uk Kim, Hwajong Kim. (2021). Drug-target interaction deep learning model study using protein multi-sequence alignment. Proceedings of Symposium of the Korean Institute of communications and Information Sciences, (), 1321-1322.
Intellectual Property
Securing Our Patents - 4 Cases
Classification
Intellectual property name
Applicant
Application country/application number
patent pending
System and method for predicting interaction of drug-target proteins including deep learning modules to predict stereostructures of target proteins
BioAI
patent pending
Deep Learning Drug Discovery Effective Substance Discovery Platform
BioAI
KOR/10-2021-0013839
KOR/10-2020-0111973
patent pending
Method of Deriving Artificial Intelligence New Drug Candidates Using Active Cliff Prediction
BioAI
KOR/10-2020-0117448
patent pending
Prediction Method of Protein Inhibition of Neurological Disease in Drugs Using Deep Learning Model
BioAI
KOR/10-2021-0013835
